Outcome for Advanced or Metastatic Soft Tissue Sarcoma of Nonextremities Treated with Doxorubicin-Based Chemotherapy: A Retrospective Study from a Single Cancer Institution

Table 3

Tumor response for different doses of doxorubicin monotherapy.

Best overall response	Doxorubicin ≧ 75 mg/m^2 (n = 16), no. (%)	Doxorubicin < 75 mg/m^2 (n = 22), no. (%)
Complete response	0 (0)	0 (0)
Partial response	2 (13)	2 (6)
Overall response	2 (13)	2 (6)
Stable disease	5 (31)	14 (44)
Progressive disease	8 (50)	6 (19)
Not evaluable or not assessed	1 (6)	0 (0)